Itraconazole + lacosamide
Itraconazole + lacosamide has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Sep 22, 2026: “Itraconazole and Lacosamide Combination Therapy Rescues CGG Repeat Expansion Induced Neurotoxicity in Fragile X-Associated Tremor/Ataxia Syndrome”.
See all 1 papers on itraconazole + lacosamide
At a glance
The findings reach worms or flies, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Department of Biotechnology, Ministry of Science and Technology, Government of India and 1 more
- Model organisms1
What did studies of itraconazole + lacosamide find?
5Studies of itraconazole + lacosamide measured 5 outcomes, among them RNA splicing, lifespan and locomotor performance.
RNA splicing
upin human cells1
1 study
RNA splicing
upin human cells1
Itraconazole + lacosamide improves RNA splicing in (CGG)99 transfected HEK293T and COS-7 cells.
“suppressed FMR1polyG aggregation and corrected CGG repeat splicing defects”
Cellsin (CGG)99 transfected HEK293T and COS-7 cells
ACS chemical neuroscience
Lifespan
upin flies1
1 study
Lifespan
upin flies1
Itraconazole + lacosamide extends lifespan in model flies.
“extended the lifespan of model flies, with a fourfold reduction in the effective ITZ dose”
Model organismsin model flies
ACS chemical neuroscience
Locomotor performance
upin flies1
1 study
Locomotor performance
upin flies1
Itraconazole + lacosamide improves locomotor performance in model flies.
“Notably, this combination also improved locomotor performance and extended the lifespan of model flies”
Model organismsin model flies
ACS chemical neuroscience
Oxidative stress and ROS signaling
downin flies1
1 study
Oxidative stress and ROS signaling
downin flies1
Itraconazole + lacosamide decreases oxidative stress and ROS signaling in an in vivo Drosophila model of FXTAS.
“attenuated oxidative stress and cell death in an in vivoDrosophila model of FXTAS”
Model organismsin an in vivo Drosophila model of FXTAS
ACS chemical neuroscience
FMR1polyG aggregation
downin flies1
1 study
FMR1polyG aggregation
downin flies1
Itraconazole + lacosamide decreases FMR1polyG aggregation in an in vivo Drosophila model of FXTAS.
“The ITZ+LCM combination significantly reduced FMR1polyG aggregation and attenuated oxidative stress and cell death in an in vivoDrosophila model of FXTAS.”
Model organismsin an in vivo Drosophila model of FXTAS
ACS chemical neuroscience